SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-10-022961
Filing Date
2010-05-25
Accepted
2010-05-25 13:46:05
Documents
5
Period of Report
2010-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CAPSTONE THERAPEUTICS 8-K 5-21-2010 form8k.htm 8-K 59943
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 51226
3 EXHIBIT 4.1 ex4_1.htm EX-4.1 17615
4 EXHIBIT 99.1 ex99_1.htm EX-99.1 16254
5 LOGO logo.jpg GRAPHIC 6108
  Complete submission text file 0001140361-10-022961.txt   155574
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33560 | Film No.: 10856339
SIC: 2834 Pharmaceutical Preparations